Introduction: The Needle in a Genomic Haystack Rare diseases, which collectively affect up to half a billion people globally, present one of modern medicine’s most formidable challenges. For patients and their families, the journey to a diagnosis is often a grueling “diagnostic odyssey” that can span years of specialist consultations, invasive tests, and uncertainty. The advent of Whole Genome Sequencing (WGS) offered a powerful new tool, allowing scientists to scan a person’s entire genetic code for the tiny variants that might be causing their illness. While this technology was a breakthrough, it created a new problem: a tsunami of genomic data. A single genome analysis can surface millions of genetic variants, and it falls to a small community of highly specialized genetic professionals to manually sift through this information. This time-intensive process is so complex that fewer than half of these initial analyses result in a diagnosis, leading to an ever-growing backlog of unsolved cases, with families left waiting for answers. Faced with this growing bottleneck, a team of researchers from Microsoft Research, Drexel University, and the Broad Institute took a refreshingly direct approach: they asked these “gene detectives” what they really need from artificial intelligence. Their answers challenge common assumptions about automation and expertise. Instead of asking for a black-box oracle to spit out answers, these frontline experts described a tool that was less about artificial genius and more about augmenting their own collective intelligence in ways few have considered. 1. AI’s Most Important Job Isn’t Replacing Experts; It’s Being the Ultimate Research Assistant When genetic professionals were asked how AI could best support their work, they didn’t envision a system that would automate their entire job. Instead, they prioritized two specific, high-effort “sensemaking” tasks that consume the bulk of their time and cognitive energy. The first was flagging cases for reanalysis. With over 1,000 new papers on gene-disease links published annually, it’s impossible for any single person to track which new scientific finding might solve an old, unsolved case. The experts wanted an AI to act as a tireless digital sentinel, immune to the fatigue and oversight that plagues its human counterparts, constantly scanning the latest research and automatically identifying which cases in their backlog could now have an answer based on new science. The second prioritized task was aggregating and synthesizing information. Currently, analysts spend hours manually foraging through numerous databases, publications, and online resources to understand a single gene or variant. They often find themselves repeating the same work done during the initial analysis, sifting through the same databases only to find nothing has changed. As one analyst noted, “Sometimes it feels like we’re repeating work that we’ve already done before.” They wanted an AI to automate this grueling process, compiling all the key information from disparate sources into a single, organized summary. A variant analyst in the study powerfully articulated this pain point: “I feel like I spend the most time digging into a gene, trying to figure out what’s known about it… that’s a lot of wasted analysis time … that AI could do much faster than I can do…” “I feel like I spend the most time digging into a gene, trying to figure out what’s known about it… that’s a lot of wasted analysis time … that AI could do much faster than I can do…” What this reveals is a fundamental reframing of AI’s role not as a replacement for human experts, but as a powerful force multiplier. It handles the most exhausting cognitive labor, freeing up human specialists for the critical work they are uniquely qualified for: interpretation, contextual judgment, and patient care. 2. From Solitary Detective to Collaborative Team The experts’ vision for AI went beyond individual assistance. They imagined using the AI-generated summaries and reports as the foundation for a shared, collaborative workspace; a concept known as “distributed sensemaking.” In this model, the AI generates the first draft of an evidence table for a specific gene. When one analyst investigates that gene, they can verify a piece of information, correct an AI error, or add a crucial note. That work then becomes instantly visible and useful to every other analyst who later investigates that same gene for a different patient. This would transform a process where work is constantly repeated into one where knowledge becomes cumulative and community-driven. The AI creates the initial artifact, and the small, distributed community of specialists collaboratively refines and builds upon it over time. This collaborative vision is not without its complexities; the experts even debated the fine-grained permissions required, suggesting that while seasoned analysts might have full edit access, trainees or external collaborators might be granted comment-only rights to maintain the integrity of the shared knowledge base. This reveals a surprisingly sophisticated vision for human-AI collaboration. It positions the AI as a central mediator that facilitates and scales collective human intelligence, helping a small community of experts share insights more effectively and drastically reduce duplicated effort. 3. Experts Have a Complicated and Smart Relationship with AI’s Filters The study revealed a sophisticated and nuanced understanding among experts about AI’s strengths and weaknesses, particularly regarding trust and control. Their preferences for how the AI should filter information were not uniform; instead, they depended entirely on the task at hand. This led to a core paradox in their design requests: For flagging cases for reanalysis, they wanted the AI to be highly selective. They worried about being overwhelmed by “too much noise” from irrelevant alerts. For this high-volume scanning task, they wanted the AI to act as an aggressive filter, only surfacing the most promising leads that were most likely to yield a diagnosis.
For summarizing evidence within a case, they wanted the exact opposite: for the AI to be completely comprehensive. They did not trust an AI to make subtle judgments about which scientific papers were relevant to a specific patient’s unique symptoms and family history. For this high-stakes interpretation task, they preferred to see all the data first and apply their own expert filters. For flagging cases for reanalysis, they wanted the AI to be highly selective. They worried about being overwhelmed by “too much noise” from irrelevant alerts. For this high-volume scanning task, they wanted the AI to act as an aggressive filter, only surfacing the most promising leads that were most likely to yield a diagnosis. For summarizing evidence within a case, they wanted the exact opposite: for the AI to be completely comprehensive. They did not trust an AI to make subtle judgments about which scientific papers were relevant to a specific patient’s unique symptoms and family history. For this high-stakes interpretation task, they preferred to see all the data first and apply their own expert filters. This is a critical insight for anyone designing AI tools for domain experts. Experts are willing to delegate the high-volume, low-nuance task of scanning the horizon for potential leads, but they demand absolute control over the high-stakes, context-rich task of interpreting the evidence for a specific patient. It’s the crucial difference between asking an AI “What’s new?” and “What does this mean for this person?” Conclusion: A New Partnership in Discovery The vision laid out by these genetic professionals is more than a feature request list; it’s a manifesto for a new era of human-AI partnership. It demands we see AI not as an autonomous replacement for expertise, but as a powerful substrate for collaboration; a tool designed to amplify human judgment, foster collective memory, and respect the critical boundaries between computational brute force and nuanced human insight. This study underscores a central theme in the future of knowledge work. The goal is not to build an AI that can do the job of a geneticist, but to build one that can help a geneticist do their job better, faster, and more collaboratively. As AI becomes a true partner in discovery, the critical question becomes: how do we shift our own roles from simply doing the work, to expertly directing the tools that magnify our ability to do it?

The is an opinion piece based on the author’s POV and does not necessarily reflect the views of HackerNoon.

3 Surprising Ways AI is Redefining the Search for Cures to Rare Diseases

About Author

Comments

TOPICS

THIS ARTICLE WAS FEATURED IN

Related Stories

Untitled Story

AI Agents and the End of Work as We Know It

The Noonification: How Often Do NFTs Pass The Howey Test? (1/13/2023)

Darwin's Hybrid Intelligence to Align AI & Human Goals for Startups & VCs

The Noonification: White Man (11/26/2022)

The Noonification: The Metaverse is a Sh*tshow (11/2/2022)

AI Agents and the End of Work as We Know It

The Noonification: How Often Do NFTs Pass The Howey Test? (1/13/2023)

Darwin's Hybrid Intelligence to Align AI & Human Goals for Startups & VCs

The Noonification: White Man (11/26/2022)

The Noonification: The Metaverse is a Sh*tshow (11/2/2022)

Light-Mode

Classic

Newspaper

Dark-Mode

Neon Noir

Minty

HN StartUps